Lunchtime session
ERS Research Initiatives
Aims : The audience will get an overview of the ERS research strategy. Examples will be presented on current successful CRC (Clinical Research Collaboration) and a new CRC. A facilitated discussion will end the session between the speakers, patient and industry representatives. This will give the pane to discuss the opportunities and risks of the strategy and for the audience to contribute to the debate.
Target audience :
Clinician, Pharmaceutical industry representative
Chairs
S. Holgate
Southampton (Hampshire)
(United Kingdom)
13:00
ERS: planning the research agenda
C. Brightling(Leicester (Leicestershire), United Kingdom)
COI
1
1376
13:20
An overview of the EMBARC consortium in terms of set-up, collaborations and external funding
E. Polverino(Barcelona, Spain)
COI
2
1377
13:40
CRC: future success SHARP
R. Djukanovic(Southampton (Hampshire), United Kingdom)
COI
3
1378
14:00
Panel discussion
4
1379
. . .